Combating emerging threats - Accelerating the availability of medical therapies

New England Journal of Medicine

Volumn 373, Issue 11, 2015, Pages 993-995

  Borio, Luciana ^a   Cox, Edward ^b   Lurie, Nicole ^c  

^a Office of the Commissioner   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PERAMIVIR; ZMAPP;

CLINICAL PROTOCOL; DRUG EFFICACY; DRUG SAFETY; EBOLA HEMORRHAGIC FEVER; EMERGENCY HEALTH SERVICE; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HUMAN; INFLUENZA; MEDICAL CARE; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; MORTALITY; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; REVIEW; WORLD HEALTH ORGANIZATION; COMMUNICABLE DISEASES, EMERGING; DISEASE OUTBREAKS; HEMORRHAGIC FEVER, EBOLA; INFECTION CONTROL; INFLUENZA A VIRUS (H1N1); INFLUENZA, HUMAN;

COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES, EMERGING; DISEASE OUTBREAKS; HEMORRHAGIC FEVER, EBOLA; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN;

EID: 84941286904     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp1508708     Document Type: Article

References (5)

1. Stockman LJ, Bellamy R, Garner P. SARS: systematic review of treatment effects. PLoS Med 2006;3(9):e343.
2. Sorbello A, Jones SC, Carter W, et al. Emergency use authorization for intravenous peramivir: evaluation of safety in the treatment of hospitalized patients infected with 2009 H1N1 influenza A virus. Clin Infect Dis 2012;55:1-7.
3. RAPIVAB (peramivir injection), for intravenous use (package insert). Durham, NC: BioCryst Pharmaceuticals (http://www .accessdata.fda.gov/drugsatfda-docs/label/2014/206426lbl.pdf).
4. Ethical considerations for use of unregistered interventions for Ebola virus disease (EVD): summary of the panel discussion. Geneva: World Health Organization, August 12, 2014 (http://www.who.int/mediacentre/news/statements/2014/ebola-ethical-review-summary/en).
5. Adebamowo C, Bah-Sow O, Binka F, et al. Randomised controlled trials for Ebola: practical and ethical issues. Lancet 2014;384: 1423-4.